# First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation

> **NCT04770142** · NA · TERMINATED · sponsor: **Tau-MEDICAL Co., Ltd.** · enrollment: 5 (actual)

## Conditions studied

- Hypertrophic Obstructive Cardiomyopathy

## Interventions

- **DEVICE:** TIRA catheter

## Key facts

- **NCT ID:** NCT04770142
- **Lead sponsor:** Tau-MEDICAL Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-21
- **Primary completion:** 2024-07-02
- **Final completion:** 2025-04-08
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** During the course of the clinical trial, sufficient subject enrollment was not achieved. As the recruitment of additional subjects was considered practically unfeasible, the clinical trial was terminated early.
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770142, "First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04770142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*